Monitor the next 10-Q for share issuance under the new plan and any impact on diluted EPS. The ~21% opposition to the incentive plan and ~12% withheld votes for one director suggest some shareholder discontent, but no immediate catalyst.
Price Chart
Executive Summary
Houlihan Lokey held its 2026 annual meeting, approving a refreshed incentive plan with 12M new shares and reduced evergreen growth (1% vs. 6%), elected a new independent director (Thomas Reichert), and executed a planned GC-to-CLO succession (Crain retired, Bhandari appointed). The vote on the incentive plan saw notable opposition (~21% against), and the proxy fight context from a DEFA14A filed 14 days prior (withdrawal of a director nominee) adds governance tension. Overall, these are routine governance and personnel changes with no financial impact.
Key Facts
- Stockholders approved the Second Amended and Restated 2016 Incentive Award Plan, adding 12,000,000 shares plus an annual evergreen increase of 1% of outstanding shares (down from 6%).
- The plan approval received 161,991,591 votes for and 42,486,557 against (~20.8% opposed), with 3,033,049 broker non-votes.
- Thomas Reichert elected as independent Class I director effective October 1, 2026, receiving a $120,000 restricted stock award vesting over three years.
- Christopher M. Crain retired as General Counsel (effective September 16, 2026) and became Corporate Senior Advisor; Prabha Sipi Bhandari appointed as Chief Legal Officer and Secretary.
- All three Class II director nominees (Irwin N. Gold, R. Scott Mund, Cyrus D. Walker) were elected; Cyrus D. Walker received 25,082,433 votes withheld (~12.2% opposition).
- Advisory vote on executive compensation passed with 193,851,865 for and 10,634,593 against.
- Ratification of KPMG LLP as auditor passed with 206,058,555 for and 1,466,760 against.
- A DEFA14A filed on September 8, 2026 disclosed that director nominee Gillian B. Zucker withdrew from standing for reelection, with no disagreement cited.
Financial Impact
No direct financial impact. The incentive plan adds up to 12M shares (plus ~1% annual evergreen) for future equity grants, but no immediate dilution or cash outlay.
Risk Factors
- Future dilution from equity grants under the refreshed plan could pressure EPS growth.
- Shareholder governance concerns may persist given the notable opposition votes and the recent director withdrawal.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-398130 |
| Document: d916717d8k.htm | 0001193125-26-398130 |
| Document: d916717dex991.htm | 0001193125-26-398130 |
| Document: 0001193125-26-398130-index-headers.html | 0001193125-26-398130 |
| Document: 0001193125-26-398130-index.html | 0001193125-26-398130 |
| Document: 0001193125-26-398130.txt | 0001193125-26-398130 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 22d ago | 8-K | $127.94 | awaiting T+20 | — | $132.35 (+3.45%) |
Sep 22, 2026 5w ago | 8-K | $129.94 $128.39 | ▼ −1.19% | ▼ −1.88% | $132.35 (+1.85%) |
Sep 8, 2026 7w ago | 8-K | $135.27 $125.22 | ▼ −7.43% | ▼ −9.63% | $132.35 (−2.16%) |
Aug 5, 2026 11w ago | Insider Buy | $127.58 $136.86 | ▲ +7.27% | ▲ +6.67% | $132.35 (+3.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers